---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-012336"
form_type: "8-K"
ticker: "PTN"
cik: "0000911216"
company_name: "PALATIN TECHNOLOGIES INC"
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T08:00:08.449367+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Palatin reports FY2023 net loss $27.5M; Vyleesi net revenue up 298%; PL9643 fully enrolled

## Summary
- Net loss of $27.5M ($2.53 diluted EPS) for FY2023 vs $36.2M loss ($3.79 EPS) in FY2022.
- Vyleesi net product revenue $4.9M in FY2023, up 298% YoY; Q4 net revenue $1.8M, up 128%.
- Phase 3 PL9643 (dry eye) fully enrolled (570 patients); topline data expected late Q4 2023.
- Phase 2 PL8177 (ulcerative colitis) interim analysis targeted Q1 2024; topline H1 2024.
- Cash $11.0M plus $2.9M receivables as of June 30; audit includes going concern paragraph.

## SEC filing metadata
- accession: 0001654954-23-012336
- form_type: 8-K
- ticker: PTN
- cik: 0000911216
- company_name: PALATIN TECHNOLOGIES INC
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/911216/000165495423012336/0001654954-23-012336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/911216/000165495423012336/ptn_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-012336
- JSON: https://secwatch.observer/filing/0001654954-23-012336.json
- Plain text: https://secwatch.observer/filing/0001654954-23-012336.txt

## Key facts
- Earnings Releases
  PALATIN TECHNOLOGIES INC reported financial results for fiscal year ended June 30, 2023.
  - Period: fiscal year ended June 30, 2023
  - Result: reported results
  source text: On September 28, 2023, we issued a press release including results for our fiscal year ended June 30, 2023 and announcing a teleconference and webcast to be held September 28, 2023, at 11:00 a.m. Eastern time, which will include a discussion on results of operations in greater detail and an update on corporate developments.
  evidence_url: https://www.sec.gov/Archives/edgar/data/911216/000165495423012336/0001654954-23-012336-index.htm
- Earnings Releases
  PALATIN TECHNOLOGIES INC reported financial results for fiscal fourth quarter ended June 30, 2023.
  - Period: fiscal fourth quarter ended June 30, 2023
  - Result: reported results
  source text: Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced financial results for its fiscal fourth quarter and fiscal year ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/911216/000165495423012336/0001654954-23-012336-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.